New study tracks transplant patients to predict a common complication

NCT ID NCT04188912

Completed Knowledge-focused Sponsor: Fred Hutchinson Cancer Center Source: ClinicalTrials.gov ↗

First seen Oct 31, 2025 · Last updated May 15, 2026 · Updated 30 times

Summary

This study followed 267 adults who had stem cell transplants to understand why some develop chronic graft-versus-host disease (GVHD), a long-term complication. Researchers collected blood, saliva, and eye fluid samples and performed exams to track early signs. The goal was to learn how to predict and catch GVHD sooner, not to test a new treatment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Cleveland Clinic

Cleveland, Ohio, 44195, United States
Fred Hutch/University of Washington Cancer Consortium

Seattle, Washington, 98109, United States
Moffitt Cancer Center

Tampa, Florida, 33612, United States
National Cancer Institute

Bethesda, Maryland, 20892, United States
Roswell Park

Buffalo, New York, 14263, United States
University of Florida

Gainesville, Florida, 32610, United States
Vanderbilt

Nashville, Tennessee, 37212, United States

Conditions

Explore the condition pages connected to this study.

HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM